James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 

Slides:



Advertisements
Similar presentations
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Advertisements

Pathophysiology of renal fluid retention
Renal manifestations in Fabry disease and therapeutic options
Volume 77, Pages S2-S8 (March 2010)
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 83, Issue 3, Pages (March 2013)
Volume 65, Issue 5, Pages (May 2004)
Progression of renal failure and hypertensive nephrosclerosis
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
John P. Middleton, Patrick H. Pun  Kidney International 
Burden of chronic kidney disease: North Africa
Pathophysiology of renal fluid retention
Francesco Paolo Schena  Kidney International 
Need for better diabetes treatment for improved renal outcome
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 70, Pages S21-S25 (December 2006)
Homocysteine and risk in end-stage renal disease: a matter of context
Anemia as a risk factor for chronic kidney disease
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
The epidemiology of chronic kidney disease
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Body size and outcomes on peritoneal dialysis in the United States
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Anemia as a risk factor for cardiovascular disease
Nephrology Crossword: History of nephrology
Fructose intake as a risk factor for kidney stone disease
Response to ‘Hepcidin levels in patients with renal disease’
Volume 73, Issue 12, Pages (June 2008)
Volume 62, Issue 3, Pages (September 2002)
Role of vitamin D receptor activators on cardiovascular risk
Volume 78, Issue 8, Pages (October 2010)
Volume 76, Issue 6, Pages (September 2009)
Volume 61, Issue 6, Pages (June 2002)
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Alternate-day dialysis may be needed for hemodialysis patients
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
Volume 87, Issue 1, Pages (January 2015)
The kidney, a cardiovascular risk marker, and a new target for therapy
Atrial fibrillation in end-stage renal disease: an emerging problem
Nephrology Crossword: Glomerulonephritis
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Unilateral renal cystic disease
A man with a hole in his penis
Prehypertension: is it relevant for nephrologists?
Homocysteine, renal function, and risk of cardiovascular disease
Volume 70, Issue 3, Pages (August 2006)
Volume 73, Issue 9, Pages (May 2008)
Cardiovascular risk assessment in kidney transplantation
Volume 64, Issue 2, Pages (August 2003)
Opportunities for a chronic disease outreach program in China
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Volume 55, Pages S3-S16 (June 1999)
The Danish Renal Biopsy Register
Pathophysiology of cardiovascular disease in hemodialysis patients
Is complement a target for therapy in renal disease?
Volume 75, Issue 7, Pages (April 2009)
Antioxidant therapy in hemodialysis patients: a systematic review
Wendy E. Hoy, Megan Rees, Emma Kile, John D. Mathews, Zhiqiang Wang 
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men  J.A. Krikken, A.T. Lely, S.J.L. Bakker,
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk  James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon  Kidney International  Volume 78, Pages S1-S7 (September 2010) DOI: 10.1038/ki.2010.209 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Prevalence of CVD risk factors in end-stage renal disease. BMI, body mass index; CVD, cardiovascular disease; Hct, hematocrit; LVH, left ventricular hypertrophy. Kidney International 2010 78, S1-S7DOI: (10.1038/ki.2010.209) Copyright © 2010 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.